Jacob Celermajer

Jacob Celermajer, founder of Cordis Asset Management and creator of Australia’s only pure play medtech fund, dives into the transformative world of medical technology. He discusses how innovation in healthcare rivals that of tech giants. Key topics include the promising investment landscape shaped by an aging population, the crucial role of medical advisory panels, and revolutionary treatments like mechanical thrombectomy that enhance patient outcomes. Celermajer offers valuable investing insights while navigating the unique challenges of the medtech sector.